AI Predicts Chemotherapy Benefit For Colorectal Patients
A Norwegian startup, DoMore Diagnostics, has developed an AI tool that analyzes scanned colorectal tumor images to predict tumor aggressiveness and likely chemotherapy benefit by learning from thousands of retrospectively labeled cases. Early evidence and parallels from a Northwestern Medicine breast-cancer tool suggest the approach may reduce unnecessary adjuvant chemotherapy, spare toxicity, and improve treatment selection if validated prospectively.
Key Points
- 1Predicts chemo benefit from histopathology images for stage 2–3 colorectal cancer patients
- 2Reduces overtreatment by identifying low-risk tumors that likely won't gain chemo survival advantage
- 3Enables clinicians to personalize therapy decisions, spare toxicity, and optimize healthcare resource use
Scoring Rationale
Relevant clinical ML advance with practical potential, limited by early-stage evidence and lack of large prospective validation.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
